Financial results - RAY MED S.R.L.

Financial Summary - Ray Med S.r.l.
Unique identification code: 15448429
Registration number: J08/943/2003
Nace: 8690
Sales - Ron
180.558
Net Profit - Ron
129.184
Employee
The most important financial indicators for the company Ray Med S.r.l. - Unique Identification Number 15448429: sales in 2023 was 180.558 euro, registering a net profit of 129.184 euro and having an average number of employees. Firma isi desfasoara activitatea in domeniul Alte activitati referitoare la sanatatea umana having the NACE code 8690.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Ray Med S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 51.783 55.300 58.473 60.295 60.535 57.051 59.675 119.228 146.528 180.558
Total Income - EUR 51.893 55.569 85.091 60.458 61.259 57.129 59.750 119.297 146.919 189.145
Total Expenses - EUR 30.158 25.197 43.218 24.932 29.212 31.541 22.434 25.078 27.184 35.342
Gross Profit/Loss - EUR 21.735 30.372 41.872 35.527 32.048 25.588 37.317 94.219 119.735 153.803
Net Profit/Loss - EUR 18.253 28.705 39.320 33.713 30.210 23.874 35.571 90.640 115.327 129.184
Employees 0 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 23.6%, from 146.528 euro in the year 2022, to 180.558 euro in 2023. The Net Profit increased by 14.207 euro, from 115.327 euro in 2022, to 129.184 in the last year.

Check the financial reports for the company - Ray Med S.r.l.

Rating financiar

Financial Rating -
Ray Med S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Ray Med S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ray Med S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Ray Med S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ray Med S.r.l. - CUI 15448429

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 36.426 29.006 4.845 36.550 58.542 42.617 28.545 14.474 2.157 906
Current Assets 39.908 64.076 92.703 79.860 80.560 116.544 157.359 131.463 167.654 190.817
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 13.417 19.761 7.157 4.142 9.375 17.487 6.144 10.653 11.560 45.928
Cash 26.491 44.316 85.546 75.717 71.185 99.057 151.215 120.809 156.095 144.889
Shareholders Funds 73.633 84.955 97.548 92.396 120.910 142.443 175.313 143.201 168.128 181.974
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 2.701 8.127 0 24.013 18.191 16.719 10.591 2.736 1.684 9.748
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "8690 - 8690"
CAEN Financial Year 8690
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 190.817 euro in 2023 which includes Inventories of 0 euro, Receivables of 45.928 euro and cash availability of 144.889 euro.
The company's Equity was valued at 181.974 euro, while total Liabilities amounted to 9.748 euro. Equity increased by 14.356 euro, from 168.128 euro in 2022, to 181.974 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Ray Med S.r.l.

Comments - Ray Med S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.